| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41948a128332f3068fb49c65d31f1a03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4681d5aa9b2a543055a71bb7fabf22f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_636323dbec29e0de694b00f5f65ccaa8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_555f7ac6fb7024238f3aadec9fb8c5a6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0233
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-195 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N63-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N65-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-38 |
| filingDate |
2005-03-25^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_641b268b574c31ba8b938ca2783ef31a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f51847c4a06a75aaee179ac0f84c06e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9c6963733d8d67b293e2bb9ee8106a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_929267fa70a1a627bc689697f34a28cd |
| publicationDate |
2005-11-24^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005260229-A1 |
| titleOfInvention |
Glycans of Anaplasma marginale major surface protein 1a, pharmaceutical compositions and methods of use |
| abstract |
Glycans derived from the N-terminal repeated peptides of Anaplasma marginale major surface protein (MSP)1a are characterized. Pharmaceutical compositions including such epitopes, and methods useful to induce or enhance an immune response against infection by ehrlichial parasites of the species Anaplasma marginale , are provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9663836-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10240217-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10227665-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10525066-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9580758-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012031270-A1 |
| priorityDate |
2000-10-30^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |